• LAST PRICE
    5.1900
  • TODAY'S CHANGE (%)
    Trending Down-0.1200 (-2.2599%)
  • Bid / Lots
    4.7000/ 1
  • Ask / Lots
    5.3900/ 2
  • Open / Previous Close
    5.3200 / 5.3100
  • Day Range
    Low 5.0500
    High 5.3200
  • 52 Week Range
    Low 4.1200
    High 17.3450
  • Volume
    46,529
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 5.31
TimeVolumeKALV
09:32 ET2645.12
09:33 ET4005.22
09:35 ET2005.07
09:37 ET2005.195
09:39 ET1005.205
09:42 ET5005.22
09:44 ET1005.2
09:46 ET1005.16
09:48 ET3005.195
09:50 ET2005.195
09:51 ET2005.09
09:53 ET1005.05
09:55 ET11005.14
09:57 ET3005.165
10:00 ET3005.135
10:02 ET3005.13
10:04 ET5005.155
10:09 ET1005.15
10:11 ET4005.165
10:15 ET2005.17
10:18 ET1005.165
10:20 ET2615.15
10:22 ET1005.15
10:24 ET1005.155
10:26 ET1005.165
10:29 ET2005.16
10:31 ET2005.165
10:33 ET2005.165
10:36 ET23005.12
10:38 ET2005.12
10:40 ET2005.15
10:42 ET2005.14
10:44 ET6425.115
10:45 ET2005.115
10:47 ET2005.115
10:49 ET2005.115
10:51 ET17005.115
10:54 ET1005.115
10:56 ET1005.115
10:58 ET2005.115
11:00 ET1005.115
11:02 ET1005.115
11:03 ET1005.11
11:05 ET8005.12
11:09 ET2005.12
11:12 ET3475.105
11:14 ET3005.105
11:18 ET1005.105
11:20 ET3005.105
11:21 ET2005.11
11:23 ET8075.13
11:25 ET1005.135
11:27 ET1005.135
11:30 ET1005.135
11:36 ET1005.135
11:38 ET1005.135
11:41 ET1005.135
11:43 ET1005.135
11:45 ET1005.135
11:50 ET1005.135
11:52 ET2005.14
11:56 ET12375.15
11:57 ET1005.165
11:59 ET1005.165
12:03 ET1005.165
12:06 ET1005.165
12:10 ET2005.165
12:14 ET1005.165
12:15 ET1005.165
12:17 ET1005.165
12:19 ET2005.165
12:21 ET1005.165
12:26 ET3005.165
12:30 ET3005.16
12:32 ET1005.155
12:33 ET7755.15
12:35 ET1005.15
12:37 ET2005.15
12:42 ET11335.17
12:44 ET1005.18
12:48 ET1005.18
12:50 ET3005.18
12:51 ET3005.18
12:53 ET4005.185
12:55 ET5005.17
12:57 ET6055.19
01:00 ET91205.19
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesKALV
Kalvista Pharmaceuticals Inc
127.7M
-1.4x
---
United StatesOLMA
Olema Pharmaceuticals Inc
127.4M
-1.3x
---
United StatesINMB
INmune Bio Inc
126.7M
-4.1x
---
United StatesXFOR
X4 Pharmaceuticals Inc
124.6M
-0.6x
---
United StatesCVM
CEL-SCI Corp
131.0M
-3.5x
---
United StatesLYRA
Lyra Therapeutics Inc
123.8M
-1.7x
---
As of 2022-11-27

Company Information

KalVista Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development and commercialization of small molecule protease inhibitors for diseases with unmet need. The Company has developed a portfolio of small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME). Plasma kallikrein is a serine protease enzyme, which is an early mediator of inflammation and edema. The body modulates the inflammatory effects of plasma kallikrein through a circulating inhibitor protein called C1-esterase inhibitor (C1-INH). The Company is primary focused on the development of the oral plasma kallikrein inhibitors for HAE. It has two drug program candidates in clinical trials. The Company’s DME program is focused on the development of an intravitreally administered small molecule plasma kallikrein inhibitor, KVD001, which completed a Phase II trial.

Contact Information

Headquarters
55 Cambridge Pkwy Ste 901ECAMBRIDGE, MA, United States 02142-1234
Phone
857-999-0075
Fax
302-531-3150

Executives

Independent Non-Executive Chairman of the Board
Brian Pereira
Chief Executive Officer, Director
Thomas Crockett
Chief Financial Officer, Chief Business Officer
Benjamin Palleiko
Senior Vice President - Development
Michael Smith
Chief Scientific Officer
Edward Feener

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$127.7M
Revenue (TTM)
$0.00
Shares Outstanding
24.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.18
EPS
$-3.64
Book Value
$7.54
P/E Ratio
-1.4x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.